A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer

BACKGROUND: We compared efficacy and safety of paclitaxel/capecitabine therapy followed by capecitabine for maintenance (PACX) versus cisplatin/capecitabine therapy (XP) in advanced gastric cancer. METHODS: Multicenter, randomized, phase III trial was conducted in China (December 2009–February 2014)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhihao, Zhang, Xiaotian, Liu, Wei, Liu, Tianshu, Hu, Bing, Li, Wei, Fan, Qingxia, Xu, Jianming, Xu, Nong, Bai, Yuxian, Pan, Yueyin, Xu, Qing, Bai, Wei, Xia, Li, Gao, Yong, Wang, Wenling, Shu, Yongqian, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097104/
https://www.ncbi.nlm.nih.gov/pubmed/29488121
http://dx.doi.org/10.1007/s10120-018-0809-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097104/
https://www.ncbi.nlm.nih.gov/pubmed/29488121
http://dx.doi.org/10.1007/s10120-018-0809-y

Ejemplares similares